Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
WB
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human eIF5A2. AA range:78-127
Subcellular Location
Cytoplasm . Nucleus . Endoplasmic reticulum membrane
Cytoplasmic side . Nucleus, nuclear pore complex . Hypusine modification promotes the nuclear export and cytoplasmic localization and there was a dynamic shift in the localization from predominantly cytoplasmic to primarily nuclear under apoptotic inducin
Peripheral membrane protein
Cytoplasmic side . Nucleus, nuclear pore complex . Hypusine modification promotes the nuclear export and cytoplasmic localization and there was a dynamic shift in the localization from predominantly cytoplasmic to primarily nuclear under apoptotic inducin
Peripheral membrane protein
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Mouse
Human Gen
56648
Observed Band
17kD
Other Name
EIF5A2
Eukaryotic initiation factor 5A isoform 2
Eukaryotic translation initiation factor 5A-2
eIF-5A-2
eIF-5A2
Eukaryotic initiation factor 5A isoform 2
Eukaryotic translation initiation factor 5A-2
eIF-5A-2
eIF-5A2
Background
function:The precise role of eIF-5A in protein biosynthesis is not known but it functions by promoting the formation of the first peptide bond.,PTM:eIF-5A seems to be the only eukaryotic protein to have an hypusine residue which is a post-translational mo